President Barack Obama has nominated Andy Slavitt to become the new administrator of CMS.
President Barack Obama has nominated Andy Slavitt to become the new administrator of CMS, reported Bloomberg. He has been acting administrator since Marilyn Tavenner stepped down from the position in February. Slavitt, who came to CMS as executive vice president of UnitedHealth Group's Optum unit, will continue to oversee day-to-day decisions regarding implementation of the Affordable Care Act (ACA), Medicare, Medicaid, the Children's Health Insurance Program, and the health insurance marketplace.
"Andy Slavitt’s depth of expertise, leadership, and innovation has made him a leader in the health care field for years," Center for American Progress President Neera Tanden said in a statement. "Throughout his career, Andy’s keen interest has been helping the health care industry better serve consumers. Seniors, children, and low-income Americans as well as people from all walks of life who rely on CMS—will be greatly served by a leader of such commitment and dedication to the best possible care for them."
In his role with UnitedHealth, Slavitt's unit worked on the ACA federally facilitated marketplace, HealthCare.gov, when it was plagued by problems in the fall of 2013. President Obama is asking the Senate to confirm his nomination. The nomination has already drawn criticism from Republicans, indicating that the confirmation will not be a smooth process.
"While Andy Slavitt’s nomination will receive thorough consideration in the Senate, it has long been clear that no one can successfully manage a law as unworkable as Obamacare," US Senate Majority Leader Mitch McConnell (R-Ky) said in a statement. "The sole focus of CMS should be to look out for our nation’s seniors and the many vulnerable Americans who use these programs, without the distraction of Obamacare.”
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More